粒子線治療の市場規模、シェア、動向分析レポート：治療タイプ別、システム別、用途別、がんタイプ別、地域別、セグメント予測、2024年～2030年

粒子線治療市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の粒子線治療市場規模は、2024年から2030年にかけて7.63%のCAGRを記録し、2030年までに25億5,000万米ドルに達すると予測されています。

市場成長の主因は、高齢者人口の増加に伴うがんの有病率の増加です。この病気は年齢に関係なく発症する可能性があるが、高齢になるにつれて発症の可能性は大幅に高まる。GLOBOCAN 2022のデータによると、がん患者の約53％が65歳以上です。この相関関係は、細胞の修復プロセスが効率的でなくなることや、特定の悪性腫瘍の危険因子が蓄積され、加齢とともに上昇することが原因と考えられます。

したがって、高齢者が国民皆保険の追求から取り残されないようにするため、各国政府は高齢者のがん患者のための変化を促進する計画を考案する必要があります。がん患者とその介護者の治療完了に対する政府支援の増加は、市場の成長を促進します。例えば、2024年4月、アルバネーゼ政府は、がん支援プログラム助成金として16.5米ドルを提供し、現在第1次募集が開始されています。このプログラムは、オーストラリア全土の個人の疾病転帰を向上させるものです。この助成金は、治療を促進する国内の小規模組織を支援することを目的としています。さらに、国際がん対策連合（UICC）は、毎年2月4日を「世界がんデー」と定め、がんや治療法に関する認識を高めています。

このような取り組みにより、予測期間中、粒子線治療の需要が促進され、市場の成長が促進されることが期待されます。コンピューティングの技術的進歩は、より速く、よりインテリジェントに、より有能な治療計画をもたらし、常時画像ガイダンス、より正確な投与、より高い線量の照射を可能にしています。その結果、効率が向上し、副作用が減少しました。線量の最適化と治療計画は、高度なコンピューターアルゴリズムによって容易になった。陽子線治療の登場は、呼吸時など患者の動きによる問題の克服に役立っています。さらに、レーザー技術の進歩により、素粒子プロセスと相互作用できる超高速二重光パルスの開発が可能になり、放射光を使った超高速原子内運動の追跡に役立っています。

さらに、疾病診断・治療センターの立ち上げが増加していることも、予測期間中の製品需要を後押ししています。例えば、2023年2月、Apollo Proton Cancer Centerは、インドで最先端の包括的ながん治療を提供するために「Dr. APJ Abdul Kalam Therapy Bay」と名付けられた陽子線ガントリーを立ち上げました。同病院は国内最大の陽子線治療（PBT）プログラムを実施し、患者の治療に当たっています。APCCは中東と南アジアで最初で唯一の陽子線治療センターです。

粒子線治療市場レポートハイライト

• 陽子線治療分野は、治療率の高さ、副作用の減少、治療継続率の高さ、有病率の増加により、2023年に最大のシェアを占めました。
• シングルルームシステムセグメントは、低コスト、小規模病院や施設での採用増加など、マルチルームシステムに対する優位性により、予測期間中に最も速いCAGRで成長すると予測されています。
• 治療セグメントは、病院での治療率、他の方法よりも粒子線治療を好む患者、治療のために病院を訪れる患者の増加により、2023年に最大のシェアを占めました。
• 小児がん分野は、世界の有病率と発生率の上昇、その治療のための粒子線治療需要の高まりにより、2023年に最大シェアを占めました。
• 北米が2023年に世界市場を席巻したのは、先進的なヘルスケアインフラ、高い有病率、有利な規制環境などの要因によるものです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 粒子線治療市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場牽引要因分析
  • 市場抑制要因分析
• 粒子線治療市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析
  • 価格分析

第4章 粒子線治療市場： 治療の推定・動向分析

• 世界の粒子線治療市場：治療タイプ別ダッシュボード
• 世界の粒子線治療市場：治療タイプ別変動分析
• 世界の粒子線治療市場：治療タイプ別、収益別
• 陽子線治療
• 重粒子線治療

第5章 粒子線治療市場：システムの推定・動向分析

• 世界の粒子線治療市場：システム別ダッシュボード
• 世界の粒子線治療市場：システム別変動分析
• 世界の粒子線治療市場：システム別、収益別
• シングルルームシステム
• マルチルームシステム

第6章 粒子線治療市場：用途の推定・動向分析

• 世界の粒子線治療市場：用途別ダッシュボード
• 世界の粒子線治療市場：用途別変動分析
• 世界の粒子線治療市場：用途別、収益別
• 治療
• 臨床調査

第7章 粒子線治療市場： がんタイプの推定・動向分析

• 世界の粒子線治療市場：がんタイプ別ダッシュボード
• 世界の粒子線治療市場：がんタイプ別変動分析
• 世界の粒子線治療市場：がんタイプ別、収益別
• 小児がん
• 乳がん
• 肺がん
• 頭頸部がん
• その他

第8章 粒子線治療市場：治療タイプ、システム、用途別の地域推定・動向分析

• 地域ダッシュボード
• 市場規模、予測動向分析、2018年から2030年：
• 北米
• 欧州
• アジア太平洋地域
• ラテンアメリカ
• 中東・アフリカ

第9章 競合情勢

• 企業/競合の分類
• 参加者概要
• 財務の概要
• 製品ベンチマーク
• 企業市場シェア分析、2023年
• 戦略マッピング
• 企業プロファイル
  • IBA Worldwide.
  • Siemens Healthcare GmbH（Varian Medical Systems, Inc.）
  • Hitachi Ltd
  • Mevion Medical Systems.
  • Provision Healthcare.
  • Optivus Proton Therapy, Inc.
  • Sumitomo Heavy Industries, Ltd.
  • ProTom International.
  • B dot Medical Inc.
  • LeyBold.
  • Advanced Oncotherapy Plc.

List of Tables

• Table 1 List of abbreviation
• Table 2 North America particle therapy market, by region, 2018 - 2030 (USD Million)
• Table 3 North America particle therapy market, By therapy type, 2018 - 2030 (USD Million)
• Table 4 North America particle therapy market, By system, 2018 - 2030 (USD Million)
• Table 5 North America particle therapy market, By application, 2018 - 2030 (USD Million)
• Table 6 U.S. particle therapy market, By therapy type, 2018 - 2030 (USD Million)
• Table 7 U.S. particle therapy market, By system, 2018 - 2030 (USD Million)
• Table 8 U.S. particle therapy market, By application, 2018 - 2030 (USD Million)
• Table 9 U.S. particle therapy market, By cancer type, 2018 - 2030 (USD Million)
• Table 10 Canada particle therapy market, By therapy type, 2018 - 2030 (USD Million)
• Table 11 Canada particle therapy market, By system, 2018 - 2030 (USD Million)
• Table 12 Canada particle therapy market, By application, 2018 - 2030 (USD Million)
• Table 13 Canada particle therapy market, By cancer type, 2018 - 2030 (USD Million)
• Table 14 Europe particle therapy market, by region, 2018 - 2030 (USD Million)
• Table 15 Europe particle therapy market, By therapy type, 2018 - 2030 (USD Million)
• Table 16 Europe particle therapy market, By system, 2018 - 2030 (USD Million)
• Table 17 Europe particle therapy market, By application, 2018 - 2030 (USD Million)
• Table 18 Europe particle therapy market, By cancer type, 2018 - 2030 (USD Million)
• Table 19 Germany particle therapy market, By therapy type, 2018 - 2030 (USD Million)
• Table 20 Germany particle therapy market, By system, 2018 - 2030 (USD Million)
• Table 21 Germany particle therapy market, By application, 2018 - 2030 (USD Million)
• Table 22 Germany particle therapy market, By cancer type, 2018 - 2030 (USD Million)
• Table 23 UK particle therapy market, By therapy type, 2018 - 2030 (USD Million)
• Table 24 UK particle therapy market, By system, 2018 - 2030 (USD Million)
• Table 25 UK particle therapy market, By application, 2018 - 2030 (USD Million)
• Table 26 UK particle therapy market, By cancer type, 2018 - 2030 (USD Million)
• Table 27 France particle therapy market, By therapy type, 2018 - 2030 (USD Million)
• Table 28 France particle therapy market, By system, 2018 - 2030 (USD Million)
• Table 29 France particle therapy market, By application, 2018 - 2030 (USD Million)
• Table 30 France particle therapy market, By cancer type, 2018 - 2030 (USD Million)
• Table 31 Italy particle therapy market, By therapy type, 2018 - 2030 (USD Million)
• Table 32 Italy particle therapy market, By system, 2018 - 2030 (USD Million)
• Table 33 Italy particle therapy market, By application, 2018 - 2030 (USD Million)
• Table 34 Italy particle therapy market, By cancer type, 2018 - 2030 (USD Million)
• Table 35 Spain particle therapy market, By therapy type, 2018 - 2030 (USD Million)
• Table 36 Spain particle therapy market, By system, 2018 - 2030 (USD Million)
• Table 37 Spain particle therapy market, By application, 2018 - 2030 (USD Million)
• Table 38 Spain particle therapy market, By cancer type, 2018 - 2030 (USD Million)
• Table 39 Denmark particle therapy market, By therapy type, 2018 - 2030 (USD Million)
• Table 40 Denmark particle therapy market, By system, 2018 - 2030 (USD Million)
• Table 41 Denmark particle therapy market, By application, 2018 - 2030 (USD Million)
• Table 42 Denmark particle therapy market, By cancer type, 2018 - 2030 (USD Million)
• Table 43 Sweden particle therapy market, By therapy type, 2018 - 2030 (USD Million)
• Table 44 Sweden particle therapy market, By system, 2018 - 2030 (USD Million)
• Table 45 Sweden particle therapy market, By application, 2018 - 2030 (USD Million)
• Table 46 Sweden particle therapy market, By cancer type, 2018 - 2030 (USD Million)
• Table 47 Norway particle therapy market, By therapy type, 2018 - 2030 (USD Million)
• Table 48 Norway particle therapy market, By system, 2018 - 2030 (USD Million)
• Table 49 Norway particle therapy market, By application, 2018 - 2030 (USD Million)
• Table 50 Norway particle therapy market, By cancer type, 2018 - 2030 (USD Million)
• Table 51 Asia Pacific particle therapy market, by region, 2018 - 2030 (USD Million)
• Table 52 Asia Pacific particle therapy market, By therapy type, 2018 - 2030 (USD Million)
• Table 53 Asia Pacific particle therapy market, By system, 2018 - 2030 (USD Million)
• Table 54 Aisa Pacific particle therapy market, By application, 2018 - 2030 (USD Million)
• Table 55 Asia Pacific particle therapy market, By cancer type, 2018 - 2030 (USD Million)
• Table 56 China particle therapy market, By therapy type, 2018 - 2030 (USD Million)
• Table 57 China particle therapy market, By system, 2018 - 2030 (USD Million)
• Table 58 China particle therapy market, By application, 2018 - 2030 (USD Million)
• Table 59 China particle therapy market, By cancer type, 2018 - 2030 (USD Million)
• Table 60 Japan particle therapy market, By therapy type, 2018 - 2030 (USD Million)
• Table 61 Japan particle therapy market, By system, 2018 - 2030 (USD Million)
• Table 62 Japan particle therapy market, By application, 2018 - 2030 (USD Million)
• Table 63 Japan particle therapy market, By cancer type, 2018 - 2030 (USD Million)
• Table 64 India particle therapy market, By therapy type, 2018 - 2030 (USD Million)
• Table 65 India particle therapy market, By system, 2018 - 2030 (USD Million)
• Table 66 India particle therapy market, By application, 2018 - 2030 (USD Million)
• Table 67 India particle therapy market, By cancer type, 2018 - 2030 (USD Million)
• Table 68 South Korea particle therapy market, By therapy type, 2018 - 2030 (USD Million)
• Table 69 South Korea particle therapy market, By system, 2018 - 2030 (USD Million)
• Table 70 South Korea particle therapy market, By application, 2018 - 2030 (USD Million)
• Table 71 South Korea particle therapy market, By cancer type, 2018 - 2030 (USD Million)
• Table 72 Australia particle therapy market, By therapy type, 2018 - 2030 (USD Million)
• Table 73 Australia particle therapy market, By system, 2018 - 2030 (USD Million)
• Table 74 Australia particle therapy market, By application, 2018 - 2030 (USD Million)
• Table 75 Australia particle therapy market, By cancer type, 2018 - 2030 (USD Million)
• Table 76 Thailand particle therapy market, By therapy type, 2018 - 2030 (USD Million)
• Table 77 Thailand particle therapy market, By system, 2018 - 2030 (USD Million)
• Table 78 Thailand particle therapy market, By application, 2018 - 2030 (USD Million)
• Table 79 Thailand particle therapy market, By cancer type, 2018 - 2030 (USD Million)
• Table 80 Latin America particle therapy market, by region, 2018 - 2030 (USD Million)
• Table 81 Latin America particle therapy market, By therapy type, 2018 - 2030 (USD Million)
• Table 82 Latin America particle therapy market, By system, 2018 - 2030 (USD Million)
• Table 83 Latin America particle therapy market, By application, 2018 - 2030 (USD Million)
• Table 84 Latin America particle therapy market, By cancer type, 2018 - 2030 (USD Million)
• Table 85 Brazil particle therapy market, By therapy type, 2018 - 2030 (USD Million)
• Table 86 Brazil particle therapy market, By system, 2018 - 2030 (USD Million)
• Table 87 Brazil particle therapy market, By application, 2018 - 2030 (USD Million)
• Table 88 Brazil particle therapy market, By cancer type, 2018 - 2030 (USD Million)
• Table 89 Mexico particle therapy market, By therapy type, 2018 - 2030 (USD Million)
• Table 90 Mexico particle therapy market, By system, 2018 - 2030 (USD Million)
• Table 91 Mexico particle therapy market, By application, 2018 - 2030 (USD Million)
• Table 92 Mexico particle therapy market, By cancer type, 2018 - 2030 (USD Million)
• Table 93 Argentina particle therapy market, By therapy type, 2018 - 2030 (USD Million)
• Table 94 Argentina particle therapy market, By system, 2018 - 2030 (USD Million)
• Table 95 Argentina particle therapy market, By application, 2018 - 2030 (USD Million)
• Table 96 Argentina particle therapy market, By cancer type, 2018 - 2030 (USD Million)
• Table 97 MEA particle therapy market, by region, 2018 - 2030 (USD Million)
• Table 98 MEA particle therapy market, By therapy type, 2018 - 2030 (USD Million)
• Table 99 MEA particle therapy market, By system, 2018 - 2030 (USD Million)
• Table 100 MEA particle therapy market, By application, 2018 - 2030 (USD Million)
• Table 101 MEA particle therapy market, By cancer type, 2018 - 2030 (USD Million)
• Table 102 South Africa particle therapy market, By therapy type, 2018 - 2030 (USD Million)
• Table 103 South Africa particle therapy market, By system, 2018 - 2030 (USD Million)
• Table 104 South Africa particle therapy market, By application, 2018 - 2030 (USD Million)
• Table 105 South Africa particle therapy market, By cancer type, 2018 - 2030 (USD Million)
• Table 106 Saudi Arabia particle therapy market, By therapy type, 2018 - 2030 (USD Million)
• Table 107 Saudi Arabia particle therapy market, By system, 2018 - 2030 (USD Million)
• Table 108 Saudi Arabia particle therapy market, By application, 2018 - 2030 (USD Million)
• Table 109 Saudi Arabia particle therapy market, By cancer type, 2018 - 2030 (USD Million)
• Table 110 UAE particle therapy market, By therapy type, 2018 - 2030 (USD Million)
• Table 111 UAE particle therapy market, By system, 2018 - 2030 (USD Million)
• Table 112 UAE particle therapy market, By application, 2018 - 2030 (USD Million)
• Table 113 UAE particle therapy market, By cancer type, 2018 - 2030 (USD Million)
• Table 114 Kuwait particle therapy market, By therapy type, 2018 - 2030 (USD Million)
• Table 115 Kuwait particle therapy market, By system, 2018 - 2030 (USD Million)
• Table 116 Kuwait particle therapy market, By application, 2018 - 2030 (USD Million)
• Table 117 Kuwait particle therapy market, By cancer type, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Primary interviews in North America
• Fig. 5 Primary interviews in Europe
• Fig. 6 Primary interviews in APAC
• Fig. 7 Primary interviews in Latin America
• Fig. 8 Primary interviews in MEA
• Fig. 9 Market research approaches
• Fig. 10 Value-chain-based sizing & forecasting
• Fig. 11 QFD modeling for market share assessment
• Fig. 12 Market formulation & validation
• Fig. 13 Particle therapy market: market outlook
• Fig. 14 Particle therapy competitive insights
• Fig. 15 Parent market outlook
• Fig. 16 Related/ancillary market outlook
• Fig. 17 Particle therapy market driver impact
• Fig. 18 Particle therapy market restraint impact
• Fig. 19 Particle therapy market: Therapy type movement analysis
• Fig. 20 Particle therapy market: Therapy type outlook and key takeaways
• Fig. 21 Proton Therapy market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 22 Heavy Ion Therapy market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 23 Particle therapy market: System movement analysis
• Fig. 24 Particle therapy market: System outlook and key takeaways
• Fig. 25 Single room systems market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 26 Multi-room systems market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 27 Particle therapy market: Application movement analysis
• Fig. 28 Particle therapy market: Application outlook and key takeaways
• Fig. 29 Treatment market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 30 Clinical research estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 31 Particle therapy market: Cancer type movement analysis
• Fig. 32 Particle therapy market: Cancer type outlook and key takeaways
• Fig. 33 Pediatric cancer market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 34 Pediatric cancer market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 35 Breast cancer market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 36 Lung cancer market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 37 Head and neck cancer market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 38 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 39 Global particle therapy market: Regional movement analysis
• Fig. 40 Global particle therapy market: Regional outlook and key takeaways
• Fig. 41 Global particle therapy market share and leading players
• Fig. 42 North America, by country
• Fig. 43 North America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44 U.S. key country dynamics
• Fig. 45 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 46 Canada key country dynamics
• Fig. 47 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 UK key country dynamics
• Fig. 50 UK market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Germany key country dynamics
• Fig. 52 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 53 France key country dynamics
• Fig. 54 France market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 55 Italy key country dynamics
• Fig. 56 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 57 Spain key country dynamics
• Fig. 58 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 59 Denmark key country dynamics
• Fig. 60 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 61 Sweden key country dynamics
• Fig. 62 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 63 Norway key country dynamics
• Fig. 64 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 65 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 66 China key country dynamics
• Fig. 67 China market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 68 Japan key country dynamics
• Fig. 69 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 70 India key country dynamics
• Fig. 71 India market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 72 Thailand key country dynamics
• Fig. 73 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 74 South Korea key country dynamics
• Fig. 75 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 76 Australia key country dynamics
• Fig. 77 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 78 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 79 Brazil key country dynamics
• Fig. 80 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 81 Mexico key country dynamics
• Fig. 82 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 83 Argentina key country dynamics
• Fig. 84 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 85 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 86 South Africa key country dynamics
• Fig. 87 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 88 Saudi Arabia key country dynamics
• Fig. 89 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 90 UAE key country dynamics
• Fig. 91 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 92 Kuwait key country dynamics
• Fig. 93 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 94 Market share of key market players- particle therapy market

Particle Therapy Market Growth & Trends:

The global particle therapy market size is anticipated to reach USD 2.55 billion by 2030, registering a CAGR of 7.63% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market growth is primarily driven by the increasing prevalence of cancer aided by the growing geriatric population. Any age can acquire the disease, but as people age, their chances of developing the disease increase significantly. According to GLOBOCAN 2022 data, approximately 53% of cancer patients were aged 65 years or older. This correlation is probably caused by less efficient cellular repair processes and the build-up of risk factors for particular malignancies, which rise with age.

Therefore, to ensure that older adults are not left behind in the pursuit of universal health coverage, governments will need to devise a plan to promote change for older adults with cancer. Increasing government support for cancer patients and their caregivers for treatment completion fuels the market's growth. For instance, in April 2024, the Albanese Government offered USD 16.5 for a Cancer Support Program grant, with the first round now open for application. This program will enhance disease outcomes for individuals all across Australia. The funding is intended to support small national organizations that promote treatment. Furthermore, the Union for International Cancer Control (UICC) celebrates 4th February as "World Cancer Day" every year to raise awareness about cancer and available options for treatment.

Such initiatives are expected to drive demand for particle beam treatment over the forecast period, driving market growth. Technological advancements in computing have resulted in faster, more intelligent, & more capable treatment planning and have enabled constant imaging guidance, more precise dosing, and delivery of higher doses. This has resulted in greater efficiency & fewer adverse effects. Dosage optimization and treatment planning have become easier owing to advanced computer algorithms. The advent of proton radiation therapy has helped overcome problems due to the movement of patients, such as during breathing. Furthermore, advances in laser technology enable the development of ultra-quick double-light pulses that can interact with the subatomic process, which helps in tracking ultrafast intra-atom motion using synchrotron radiation.

Moreover, the growing launch of disease diagnosis and treatment centers drives demand for products during the forecast period. For instance, in February 2023, the Apollo Proton Cancer Center launched a Proton Gantry named "Dr. APJ Abdul Kalam Therapy Bay" to offer the most advanced and comprehensive cancer care in India. The hospital administers the nation's largest Proton Beam Therapy (PBT) program to treat patients. APCC is the first and only proton therapy center in the Middle East and South Asia.

Particle Therapy Market Report Highlights:

• The proton therapy segment held the largest share in 2023 due to the disease's high treatment rate, decreased side effects, high treatment adherence rate, and growing prevalence
• The single-room systems segment is expected to grow at the fastest CAGR during the forecast period due to its advantages over multi-room systems, such as low cost, and increased adoption by smaller hospitals and facilities
• The treatment segment held the largest share in 2023 due to hospital treatment rates, patient preference for particle therapy over other methods, and an increasing number of patients visiting hospitals for treatment
• The pediatric cancer segment held the largest in 2023 owing to a rise in the prevalence and incidence of the disease worldwide and rising demand for particle therapy for its treatment
• North America dominated the global market in 2023 owing to factors advanced healthcare infrastructure, high disease prevalence, and a favorable regulatory environment

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Therapy Type
  • 1.2.2. System
  • 1.2.3. Application
  • 1.2.4. Cancer Type
  • 1.2.5. Regional scope
  • 1.2.6. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Therapy type and system Outlook
  • 2.2.2. Application and cancer type outlook
  • 2.2.3. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Particle Therapy Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Growing prevalence of cancer
    • 3.2.1.2. Increasing awareness about benefits of particle therapy
    • 3.2.1.3. Rising geriatric population
    • 3.2.1.4. Technological advancements in particle therapy
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Lack of skilled radiotherapy professionals
    • 3.2.2.2. Stringent regulatory policies
    • 3.2.2.3. Adverse effects of particle therapy
• 3.3. Particle Therapy Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
  • 3.3.3. Pricing Analysis

Chapter 4. Particle Therapy Market: Therapy Estimates & Trend Analysis

• 4.1. Global Particle Therapy Market: Therapy Type Dashboard
• 4.2. Global Particle Therapy Market: Therapy Type Movement Analysis
• 4.3. Global Particle Therapy Market By Therapy Type, Revenue
• 4.4. Proton Therapy
  • 4.4.1. Proton Therapy market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Heavy Ion Therapy
  • 4.5.1. Heavy Ion Therapy market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Particle Therapy Market: System Estimates & Trend Analysis

• 5.1. Global Particle Therapy Market: System Dashboard
• 5.2. Global Particle Therapy Market: System Movement Analysis
• 5.3. Global Particle Therapy Market By System, Revenue
• 5.4. Single Room Systems
  • 5.4.1. Single room systems market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Multi-room Systems
  • 5.5.1. Multi-room systems market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Particle Therapy Market: Application Estimates & Trend Analysis

• 6.1. Global Particle Therapy Market: Application Dashboard
• 6.2. Global Particle Therapy Market: Application Movement Analysis
• 6.3. Global Particle Therapy Market By Application, Revenue
• 6.4. Treatment
  • 6.4.1. Treatment market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Clinical Research
  • 6.5.1. Clinical research market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Particle Therapy Market: Cancer Type Estimates & Trend Analysis

• 7.1. Global Particle Therapy Market: Cancer Type Dashboard
• 7.2. Global Particle Therapy Market: Cancer Type Movement Analysis
• 7.3. Global Particle Therapy Market By Cancer Type, Revenue
• 7.4. Pediatric Cancer
  • 7.4.1. Pediatric cancer market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Breast Cancer
  • 7.5.1. Breast Cancer market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Lung Cancer
  • 7.6.1. Lung cancer market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. Head and Neck Cancer
  • 7.7.1. Head and neck cancer market estimates and forecasts 2018 to 2030 (USD Million)
• 7.8. Others
  • 7.8.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Particle Therapy Market: Regional Estimates & Trend Analysis By Therapy Type, System, and Application

• 8.1. Regional Dashboard
• 8.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 8.3. North America
  • 8.3.1. U.S.
    • 8.3.1.1. Key country dynamics
    • 8.3.1.2. Regulatory framework/ reimbursement structure
    • 8.3.1.3. Competitive scenario
    • 8.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.3.2. Canada
    • 8.3.2.1. Key country dynamics
    • 8.3.2.2. Regulatory framework/ reimbursement structure
    • 8.3.2.3. Competitive scenario
    • 8.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 8.4. Europe
  • 8.4.1. UK
    • 8.4.1.1. Key country dynamics
    • 8.4.1.2. Regulatory framework/ reimbursement structure
    • 8.4.1.3. Competitive scenario
    • 8.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.2. Germany
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Regulatory framework/ reimbursement structure
    • 8.4.2.3. Competitive scenario
    • 8.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.3. France
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Regulatory framework/ reimbursement structure
    • 8.4.3.3. Competitive scenario
    • 8.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.4. Italy
    • 8.4.4.1. Key country dynamics
    • 8.4.4.2. Regulatory framework/ reimbursement structure
    • 8.4.4.3. Competitive scenario
    • 8.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.5. Spain
    • 8.4.5.1. Key country dynamics
    • 8.4.5.2. Regulatory framework/ reimbursement structure
    • 8.4.5.3. Competitive scenario
    • 8.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.6. Norway
    • 8.4.6.1. Key country dynamics
    • 8.4.6.2. Regulatory framework/ reimbursement structure
    • 8.4.6.3. Competitive scenario
    • 8.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.7. Sweden
    • 8.4.7.1. Key country dynamics
    • 8.4.7.2. Regulatory framework/ reimbursement structure
    • 8.4.7.3. Competitive scenario
    • 8.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.8. Denmark
    • 8.4.8.1. Key country dynamics
    • 8.4.8.2. Regulatory framework/ reimbursement structure
    • 8.4.8.3. Competitive scenario
    • 8.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Japan
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Regulatory framework/ reimbursement structure
    • 8.5.1.3. Competitive scenario
    • 8.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.2. China
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Regulatory framework/ reimbursement structure
    • 8.5.2.3. Competitive scenario
    • 8.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.3. India
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Regulatory framework/ reimbursement structure
    • 8.5.3.3. Competitive scenario
    • 8.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.4. Australia
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Regulatory framework/ reimbursement structure
    • 8.5.4.3. Competitive scenario
    • 8.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.5. South Korea
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Regulatory framework/ reimbursement structure
    • 8.5.5.3. Competitive scenario
    • 8.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.6. Thailand
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Regulatory framework/ reimbursement structure
    • 8.5.6.3. Competitive scenario
    • 8.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 8.6. Latin America
  • 8.6.1. Brazil
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Regulatory framework/ reimbursement structure
    • 8.6.1.3. Competitive scenario
    • 8.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.2. Mexico
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Regulatory framework/ reimbursement structure
    • 8.6.2.3. Competitive scenario
    • 8.6.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.3. Argentina
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Regulatory framework/ reimbursement structure
    • 8.6.3.3. Competitive scenario
    • 8.6.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 8.7. MEA
  • 8.7.1. South Africa
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Regulatory framework/ reimbursement structure
    • 8.7.1.3. Competitive scenario
    • 8.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.2. Saudi Arabia
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Regulatory framework/ reimbursement structure
    • 8.7.2.3. Competitive scenario
    • 8.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.3. UAE
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Regulatory framework/ reimbursement structure
    • 8.7.3.3. Competitive scenario
    • 8.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.4. Kuwait
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Regulatory framework/ reimbursement structure
    • 8.7.4.3. Competitive scenario
    • 8.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company/Competition Categorization
• 9.2. Participant Overview
• 9.3. Financial Overview
• 9.4. Product Benchmarking
• 9.5. Company Market Share Analysis, 2023
• 9.6. Strategy Mapping
• 9.7. Company Profiles
  • 9.7.1. IBA Worldwide.
    • 9.7.1.1. Company overview
    • 9.7.1.2. Financial performance
    • 9.7.1.3. benchmarking
    • 9.7.1.4. Strategic initiatives
  • 9.7.2. Siemens Healthcare GmbH (Varian Medical Systems, Inc.)
    • 9.7.2.1. Company overview
    • 9.7.2.2. Financial performance
    • 9.7.2.3. benchmarking
    • 9.7.2.4. Strategic initiatives
  • 9.7.3. Hitachi Ltd
    • 9.7.3.1. Company overview
    • 9.7.3.2. Financial performance
    • 9.7.3.3. benchmarking
    • 9.7.3.4. Strategic initiatives
  • 9.7.4. Mevion Medical Systems.
    • 9.7.4.1. Company overview
    • 9.7.4.2. Financial performance
    • 9.7.4.3. benchmarking
    • 9.7.4.4. Strategic initiatives
  • 9.7.5. Provision Healthcare.
    • 9.7.5.1. Company overview
    • 9.7.5.2. Financial performance
    • 9.7.5.3. benchmarking
    • 9.7.5.4. Strategic initiatives
  • 9.7.6. Optivus Proton Therapy, Inc.
    • 9.7.6.1. Company overview
    • 9.7.6.2. Financial performance
    • 9.7.6.3. benchmarking
    • 9.7.6.4. Strategic initiatives
  • 9.7.7. Sumitomo Heavy Industries, Ltd.
    • 9.7.7.1. Company overview
    • 9.7.7.2. Financial performance
    • 9.7.7.3. benchmarking
    • 9.7.7.4. Strategic initiatives
  • 9.7.8. ProTom International.
    • 9.7.8.1. Company overview
    • 9.7.8.2. Financial performance
    • 9.7.8.3. benchmarking
    • 9.7.8.4. Strategic initiatives
  • 9.7.9. B dot Medical Inc.
    • 9.7.9.1. Company overview
    • 9.7.9.2. Financial performance
    • 9.7.9.3. benchmarking
    • 9.7.9.4. Strategic initiatives
  • 9.7.10. LeyBold.
    • 9.7.10.1. Company overview
    • 9.7.10.2. Financial performance
    • 9.7.10.3. benchmarking
    • 9.7.10.4. Strategic initiatives
  • 9.7.11. Advanced Oncotherapy Plc.
    • 9.7.11.1. Company overview
    • 9.7.11.2. Financial performance
    • 9.7.11.3. benchmarking
    • 9.7.11.4. Strategic initiatives